Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Anti-CD38 + KRAS Vaccine + Anti-PD-1 for Pancreatic & Lung Cancer
Recruiting1 awardPhase 2
Washington, District of Columbia
This trial tests a combination of drugs to see if it can help stop or control advanced NSCLC/PDAC and how well participants' bodies handle it.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service